ArticleFrontiers in public health2024
Development and validation of a risk prediction model for dyslipidemia in community-dwelling middle-aged and older adults in China: a nationwide survey.
Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The incidence of dyslipidemia as a risk factor for many serious diseases is increasing year by year. This study aimed to construct and visualize a risk prediction model for dyslipidemia in middle-aged and older adults. Method: The subjects of our study are derived from CHARLS. Participants were allocated to training and validation groups in a 7:3 ratio at random. To identify potential predictors of dyslipidemia, we employed univariate analysis, lasso regression, and multivariate binary logistic regression analyses. A nomogram was constructed based on logistic regression results, and a ROC curve was used to evaluate its predictive performance. The accuracy and discriminatory capability were assessed using calibration curve analysis, while the net clinical benefit rate was evaluated through decision curve analysis (DCA). Results: Our study included a total of 12,589 participants, of which 1,514 were detected with dyslipidemia syndrome. Model construction: Based on the results of the logistic regression analysis of the training set, six variables were selected to construct the model, which were ranked in order of importance as comorbid hypertension, comorbid diabetes, waistline, comorbid digestive disease, place of abode, and comorbid liver disease. The ROC curve results indicated that the prediction model exhibited moderate discriminatory ability (AUC > 0.7). Additionally, the calibration curve confirmed the model's strong predictive accuracy. The decision curve analysis (DCA) illustrated a positive net benefit associated with the prediction model. Conclusions: The prediction model of dyslipidemia risk in middle-aged and older adults constructed in this study has good efficacy and helps to screen high-risk groups.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.